Taken together, these results highlight the atherogenic role of caspase-1 in HIV-associated macrophage activation and atherosclerosis and indicate that therapeutic inhibition of caspase-1 may have a beneficial effect on treating HIV-associated atherosclerosis. This evidence concerns the gene CASP1 and atherosclerosis.